3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:August 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:August 28, 2023Completed
Condition(s):Oncogenic Osteomalacia; Mesenchymal TumorLast Updated:April 7, 2017Unknown status
Condition(s):Ganglioneuroblastoma; Ganglioneuroma; NeuroblastomaLast Updated:December 7, 2023Recruiting
Condition(s):Neuroendocrine TumorsLast Updated:January 30, 2024Recruiting
Condition(s):Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v7Last Updated:March 7, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.